Answers are grounded in this paper and cite their sources.
With the aim to replace the natural amino acid proline by a proline mimetic structure, a cyclopent-2-enecarbonyl moiety was studied at the P2 position of prolyl oligopeptidase (POP) inhibitors. The cyclopent-2-enecarbonyl moiety proved to be an excellent proline mimetic at the P2 position of POP inhibitors. The replacement is particularly useful when increased lipophilicity is needed.
No takes yet. Share an insight, caveat, or question.
Jarho et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: